Melanoma Soars Among Young Adults
A new study has revealed an alarming rise in melanoma among people aged 18 to 39: over the past 40 years, rates of this potentially deadly skin cancer grew by 800 percent among young women and 400 percent among young men.
FDA Approves Two Drugs, Companion Diagnostic Test for Advanced Skin Cancer
The U.S. Food and Drug Administration has approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
New Genetic Study Strengthens Link Between UV Radiation and Melanoma
A new study appearing in the journal Nature greatly reinforces the findings of an earlier landmark genetic study linking damage from the sun’s ultraviolet rays (UVR) to melanoma, the …
New Study Shows Zelboraf Can Double Melanoma Patients’ Life Expectancy
A new study published in the February 22, 2012 issue of the New England Journal of Medicine shows that the drug ZelborafTM can reduce or eliminate tumors, delay disease progression, and extend life …
Nonmelanoma Skin Cancers Raise the Risk for Other Cancers
People who have had the nonmelanoma skin cancers (NMSCs) basal and squamous cell carcinoma (BCC and SCC) are approximately twice as likely as other people to develop non-skin cancers, according to a …
Melanoma Affects Women More Strongly than Men
IN THE HEADLINES...Melanoma appears to have a stronger overall impact on women than men, according to a new report.
In a study of 562 men and women published this month in the Archives of …